In this new role Justine Trinidad will work collaboratively with Kathryn Gallant, CEO of Cello Health Insight US, to ensure the smooth daily operations of the New York office. Justine joined Cello Health Insight as a Director in February 2017 to lead the business’s quantitative research practice ‘IQ’ in the US, and under Justine’s very capable leadership, IQ has seen substantial growth in the US in terms of revenue, as well headcount. Justine will retain these existing responsibilities – leading the IQ team alongside her new responsibilities as managing director.
“As we have grown, and built our presence in the US market, the need for a dedicated managing director serving our New York office has arisen, and with her proven ability leadership capacity, Justine was a natural choice.” – Kathryn Gallant, CEO Cello Health Insight US
Justine has 20 years of quantitative and qualitative market research experience spanning both the vendor- and client-sides. Most recently Justine worked as a Director at Pacira Pharmaceuticals prior to which she served in a variety of roles at The Nielsen Company.